FDA Approves New Heart Failure Medication

Research suggests the new drug helps reduce heart failure-related hospitalizations and deaths due to cardiovascular disease.

A new medication will soon be available to heart failure patients, after a large study of the drug was stopped early in response to better-than-expected results.The medication is an angiotensin receptor-neprilysin inhibitor known as LCZ696 (Entresto). The U.S. Food and Drug Administration approved the drug earlier this summer. The drug helps widen arteries to improve blood flow, and, at the same time, helps lower the volume of fluid in the body. Last fall it was on Cleveland Clinics Top 10 Innovations for 2015-an annual list of medical breakthroughs expected in the coming year.
To continue reading this article you must be a paid subscriber

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!


Please enter your comment!
Please enter your name here